{"id":4910,"date":"2014-01-13T14:22:03","date_gmt":"2014-01-13T13:22:03","guid":{"rendered":"http:\/\/blog.cofb.cat\/?p=4910"},"modified":"2014-01-13T14:22:03","modified_gmt":"2014-01-13T13:22:03","slug":"avaluacio-economica-de-medicaments-2","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/","title":{"rendered":"Estat de l&#8217;avaluaci\u00f3 dels medicaments a Catalunya"},"content":{"rendered":"\n<p>En qu\u00e8 consisteix l&#8217;avaluaci\u00f3 econ\u00f2mica de medicaments? Quina \u00e9s la perspectiva actual? Com es realitza a Espanya i a Catalunya l&#8217;avaluaci\u00f3? Aquestes s\u00f3n algunes de les preguntes que es van respondre a la confer\u00e8ncia &#8220;<strong>Estat actual de l&#8217;avaluaci\u00f3 dels medicaments a Catalunya<\/strong>&#8221; que va acollir el Col\u00b7legi el 3 de desembre.<\/p>\n<p>L&#8217;acte, adre\u00e7at a farmac\u00e8utics d&#8217;atenci\u00f3 prim\u00e0ria i farmac\u00e8utics d&#8217;hospitals, el van coordinar Julio Mart\u00ednez, cap de farm\u00e0cia de la Vall d&#8217;Hebron i president de la Societat Catalana de Farm\u00e0cia Cl\u00ednica (SCFC);\u00a0Tom\u00e0s Casas\u00edn, cap de farm\u00e0cia de l&#8217;Hospital de Viladecans i vocal d&#8217;Hospitals del COFB, i\u00a0Roser Vall\u00e9s, responsable Gesti\u00f3 Activitat Farm\u00e0cia SAP Vall\u00e9s Occidental\u00a0DAP Metropolitana Nord, ICS i vocal d&#8217;Atenci\u00f3 Prim\u00e0ria del COFB.<\/p>\n<p>En primer lloc, el ponent\u00a0Francesc Puigvent\u00f3s, fundador del Grup Genesi, va parlar de <strong>l&#8217;experi\u00e8ncia d&#8217;avaluaci\u00f3 en la perspectiva actual.<\/strong> &#8220;Un dels elements m\u00e9s dif\u00edcils per fer un informe d&#8217;avaluaci\u00f3 \u00e9s el preu&#8221;, va afirmar, alhora que va destacar la import\u00e0ncia que el Ministeri faciliti tota la informaci\u00f3 al respecte. &#8220;Les\u00a0comunitats aut\u00f2nomes estan potenciant estructures d&#8217;avaluaci\u00f3&#8221;, va comentar.<\/p>\n<p>El seg\u00fcent punt a tractar va ser <strong>el rol de l&#8217;Ag\u00e8ncia de Qualitat i Avaluaci\u00f3 Sanit\u00e0ries de Catalunya (AQuAS)<\/strong>\u00a0en l&#8217;avaluaci\u00f3 de medicaments, a c\u00e0rrec de la farmac\u00e8utica Ana Maria de Andr\u00e9s. AQuAS \u00e9s una empresa p\u00fablica adscrita al Departament de Salut de la Generalitat i el seu principal client, dins l&#8217;\u00e0mbit de la farm\u00e0cia, \u00e9s CatSalut. La seva labor est\u00e0 focalitzada en l&#8217;avaluaci\u00f3, i tal com explica De Andr\u00e9s, es fa tenint en compte tres vessants: les\u00a0tecnologies m\u00e8diques, els medicaments i la investigaci\u00f3.<\/p>\n<p>Per \u00faltim, Tatiana Dilla, gerent de farmacoeconomia de Lilly, patrocinador de la confer\u00e8ncia, va centrar-se en\u00a0<strong>l&#8217;avaluaci\u00f3 econ\u00f2mica de medicaments a Espanya, la seva situaci\u00f3 actual i les perspectives de futur.<\/strong>\u00a0&#8220;El resultat final de qualsevol avaluaci\u00f3 econ\u00f2mica \u00e9s el cost efectivitat incremental&#8221;. &#8220;Al seu torn -va prosseguir Dilla- per tal de poder realitzar b\u00e9 aquesta avaluaci\u00f3 es necessiten recursos humans, professionals especialitzats i recursos econ\u00f2mics&#8221;.<\/p>\n<h6 style=\"text-align: right;\"><strong>Amb el patrocini de:\u00a0<\/strong><\/h6>\n<p><img decoding=\"async\" class=\"alignright\" alt=\"\" src=\"http:\/\/www.cofb.net\/image\/image_gallery?img_id=1800&amp;large=1&amp;key=361640\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>En qu\u00e8 consisteix l&#8217;avaluaci\u00f3 econ\u00f2mica de medicaments? Quina \u00e9s la perspectiva actual? Com es realitza a Espanya i a Catalunya l&#8217;avaluaci\u00f3? Aquestes s\u00f3n algunes de les preguntes que es van respondre a la confer\u00e8ncia &#8220;Estat actual de l&#8217;avaluaci\u00f3 dels medicaments a Catalunya&#8221; que va acollir el Col\u00b7legi el 3 de [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":4920,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[57],"tags":[938,70,481],"class_list":["post-4910","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mon-collegial","tag-atencio-primaria","tag-formacio","tag-hospitals"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Estat de l&#039;avaluaci\u00f3 dels medicaments a Catalunya - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Estat de l&#039;avaluaci\u00f3 dels medicaments a Catalunya - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"En qu\u00e8 consisteix l&#8217;avaluaci\u00f3 econ\u00f2mica de medicaments? Quina \u00e9s la perspectiva actual? Com es realitza a Espanya i a Catalunya l&#8217;avaluaci\u00f3? Aquestes s\u00f3n algunes de les preguntes que es van respondre a la confer\u00e8ncia &#8220;Estat actual de l&#8217;avaluaci\u00f3 dels medicaments a Catalunya&#8221; que va acollir el Col\u00b7legi el 3 de [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-01-13T13:22:03+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Estat de l&#8217;avaluaci\u00f3 dels medicaments a Catalunya\",\"datePublished\":\"2014-01-13T13:22:03+00:00\",\"dateModified\":\"2014-01-13T13:22:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/\"},\"wordCount\":399,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"Atenci\u00f3 prim\u00e0ria\",\"Formaci\u00f3\",\"Hospitals\"],\"articleSection\":[\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/\",\"name\":\"Estat de l'avaluaci\u00f3 dels medicaments a Catalunya - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2014-01-13T13:22:03+00:00\",\"dateModified\":\"2014-01-13T13:22:03+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Estat de l&#8217;avaluaci\u00f3 dels medicaments a Catalunya\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Estat de l'avaluaci\u00f3 dels medicaments a Catalunya - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/","og_locale":"ca_ES","og_type":"article","og_title":"Estat de l'avaluaci\u00f3 dels medicaments a Catalunya - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"En qu\u00e8 consisteix l&#8217;avaluaci\u00f3 econ\u00f2mica de medicaments? Quina \u00e9s la perspectiva actual? Com es realitza a Espanya i a Catalunya l&#8217;avaluaci\u00f3? Aquestes s\u00f3n algunes de les preguntes que es van respondre a la confer\u00e8ncia &#8220;Estat actual de l&#8217;avaluaci\u00f3 dels medicaments a Catalunya&#8221; que va acollir el Col\u00b7legi el 3 de [&hellip;]","og_url":"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2014-01-13T13:22:03+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"wpAdminCofbOrg","Temps estimat de lectura":"2 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Estat de l&#8217;avaluaci\u00f3 dels medicaments a Catalunya","datePublished":"2014-01-13T13:22:03+00:00","dateModified":"2014-01-13T13:22:03+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/"},"wordCount":399,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/#primaryimage"},"thumbnailUrl":"","keywords":["Atenci\u00f3 prim\u00e0ria","Formaci\u00f3","Hospitals"],"articleSection":["M\u00f3n col\u00b7legial"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/","url":"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/","name":"Estat de l'avaluaci\u00f3 dels medicaments a Catalunya - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/#primaryimage"},"thumbnailUrl":"","datePublished":"2014-01-13T13:22:03+00:00","dateModified":"2014-01-13T13:22:03+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Estat de l&#8217;avaluaci\u00f3 dels medicaments a Catalunya"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"En qu\u00e8 consisteix l&#8217;avaluaci\u00f3 econ\u00f2mica de medicaments? Quina \u00e9s la perspectiva actual? Com es realitza a Espanya i a Catalunya l&#8217;avaluaci\u00f3? Aquestes s\u00f3n algunes de les preguntes que es van respondre a la confer\u00e8ncia &#8220;Estat actual de l&#8217;avaluaci\u00f3 dels medicaments a Catalunya&#8221; que va acollir el Col\u00b7legi el 3 de [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/4910","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=4910"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/4910\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=4910"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=4910"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=4910"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}